Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gaucher disease: complexity in a "simple" disorder.

Ellen Sidransky1

  • 1Section on Molecular Neurogenetics, NIMH 35 Convent Drive MSC 3708, 1A-213, Bethesda, MD 20892-3708, USA. sidranse@irp.nimh.nih.gov

Molecular Genetics and Metabolism
|October 7, 2004
PubMed
Summary

Gaucher disease, a genetic disorder, is linked to an increased risk of developing parkinsonism. This research explores how glucocerebrosidase gene mutations contribute to Gaucher disease and Parkinson disease risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacotherapies for Gaucher disease: what's new on the horizon?

Expert opinion on pharmacotherapy·2026
Same author

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.

The Lancet. Neurology·2026
Same author

Commentary on Prenatal Testing of a Complex Pathogenic Variant following Positive Carrier Screening for Gaucher Disease.

Clinical chemistry·2025
Same author

The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in <i>GBA1</i> isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism.

bioRxiv : the preprint server for biology·2025
Same author

Dissecting the biological impact of <i>GBA1</i> mutations using multi-omics in an isogenic setting.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Background:

  • Gaucher disease is the most common sphingolipidosis, caused by glucocerebrosidase deficiency, presenting diverse clinical forms.
  • Genotype-phenotype correlations in Gaucher disease show significant heterogeneity.
  • The glucocerebrosidase gene (GBA) locus on chromosome 1q is complex, with a homologous pseudogene influencing mutation etiology.

Purpose of the Study:

  • Investigate the link between Gaucher disease and atypical manifestations like parkinsonism.
  • Determine if genetic or environmental factors contribute to Gaucher disease phenotypes.
  • Explore the role of glucocerebrosidase alterations in both Gaucher disease and sporadic Parkinson disease.

Main Methods:

  • Studied patients with Gaucher disease and atypical symptoms, including parkinsonism.

Related Experiment Videos

  • Performed neuropathological examination of brain tissue for alpha-synuclein.
  • Analyzed the GBA gene sequence in autopsy samples from Parkinson disease patients.

    • Main Results:

    • Gaucher disease patients with specific genotypes can develop early-onset parkinsonism with Lewy bodies.
    • Family studies suggest increased parkinsonism incidence in Gaucher disease heterozygotes.
    • GBA sequence alterations were found in 14% of sporadic Parkinson disease cases.

    Conclusions:

    • Altered glucocerebrosidase function may increase vulnerability to parkinsonism.
    • Gaucher disease insights illuminate the etiology of complex genetic diseases like Parkinson disease.
    • Heterozygosity for Gaucher disease mutations might be a risk factor for complex diseases.